Company Filing History:
Years Active: 2024
Title: Yeun Ju Kim: Innovator in Bispecific Antibodies
Introduction
Yeun Ju Kim is a prominent inventor based in Seongnam-Si, South Korea. She has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. Her innovative work aims to enhance therapeutic options for various diseases.
Latest Patents
Yeun Ju Kim holds a patent for "Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereof." This patent describes a bispecific antibody that effectively blocks the interactions between PD-L1 and its receptor PD-1, as well as between LAG3 and its ligand. The bispecific antibody demonstrates high binding affinity to both PD-L1 and LAG3 proteins, which are crucial in immune response modulation.
Career Highlights
Yeun Ju Kim is associated with Abl Bio Inc., a company focused on developing innovative biopharmaceuticals. Her work at Abl Bio Inc. has positioned her as a key player in the advancement of therapeutic antibodies. She has successfully contributed to the research and development of novel treatments that target critical pathways in cancer and other diseases.
Collaborations
Some of her notable coworkers include Eunyoung Park and Yangsoon Lee. Their collaborative efforts have further strengthened the research initiatives at Abl Bio Inc. Together, they work towards achieving breakthroughs in antibody therapies.
Conclusion
Yeun Ju Kim's contributions to the field of bispecific antibodies exemplify her dedication to advancing medical science. Her innovative patent and collaborative work at Abl Bio Inc. highlight her role as a leading inventor in biomedicine.